Plain-English translation of NCT07605819 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Enzeavour assay, a simple blood test that looks for specific enzyme markers that may indicate early pancreatic cancer. Researchers want to see how well this blood test works at finding pancreatic cancer in people who feel healthy and have no symptoms. The study will involve about 10,000 people in Japan.
Pancreatic cancer is often found very late, when it's harder to treat. This trial exists because there is no good, easy screening method available yet. The Enzeavour assay could help catch pancreatic cancer much earlier, when treatment might be more effective.
You likely qualify if…
You likely don't qualify if…
You will have a blood sample drawn during a routine health checkup or cancer screening visit. The blood will be tested using the Enzeavour assay. If your test score is higher than the cutoff, you will be referred for follow-up imaging tests (such as MRI, ultrasound, or CT scans) to confirm whether you have pancreatic cancer. The study includes 12-month follow-up for certain groups of participants.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Japan